Image source: Canva The California Institute for Regenerative Medicine (CIRM) recently awarded $8 million to Rochelle Emery, MD, at Senti Bio to advance a clinical trial for a novel therapy targeting two forms of blood cancer, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). About AML and MDS Both cancers have a five‑year survival rate … Continue reading CIRM Supports Groundbreaking Gene Therapy for AML and MDS
clinical trials
CIRM awards boost clinical trials for cancer, heart, and rare diseases
The California Institute for Regenerative Medicine (CIRM) has allocated $26 million to support clinical research targeting cancers, heart conditions, and rare diseases. This investment reinforces CIRM’s commitment to advancing innovative stem cell and gene therapy treatments through all stages of clinical development. This round of awards funds five projects within CIRM’s Clinical Program, which provides … Continue reading CIRM awards boost clinical trials for cancer, heart, and rare diseases
Where Are They Now: Jake Javier
On the first day, of the 2024 CIRM Trainee Network Conference, Jake Javier took shared his experience as a clinical trial patient, as how he benefited from the innovative trial. The event done in partnership with the University of Southern California (USC) gave trainees from CIRM’s education and training programs an opportunity to engage with … Continue reading Where Are They Now: Jake Javier
A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
At the California Institute for Regenerative Medicine (CIRM), we highlight achievements from the research we support. We recently spoke with Cory Nicholas, PhD, CEO and Co‑Founder of Neurona Therapeutics, about a major milestone for the clinical‑stage company. Neurona received the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation for NRTX‑1001, a CIRM‑funded neural cell therapy for … Continue reading A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
Supporting a CAR-T cell trial for kidney cancer
Photo Credit: Allogene Therapeutics. Image of the ALLO-316 allogeneic CAR-T cell therapy. The California Institute for Regenerative Medicine (CIRM) awarded $15 million to Dr. John Le Gall and his team at Allogene Therapeutics. This funding will support the development of ALLO-316, an innovative anti-CD70 CAR-T cell product designed to treat metastatic clear cell renal cell … Continue reading Supporting a CAR-T cell trial for kidney cancer
CIRM’s $31 million boost for cancer and eye disease research
The California Institute for Regenerative Medicine (CIRM) recently approved nearly $31 million in funding, further cementing our commitment to advancing the field of regenerative medicine. This substantial investment aims to drive clinical research targeting various cancers and eye diseases. CIRM’s dedication to fostering innovative treatments is demonstrated through its clinical program, which funds eligible stem … Continue reading CIRM’s $31 million boost for cancer and eye disease research
Tackling sickle cell disease from within
Photo Credit: Jaquell Chandler Evie Junior was born with sickle cell disease, a life-threatening condition that affects around 100,000 Americans, most of them Black and Latino. People with sickle cell disease have blood cells that are shaped like a hook (or sickle) rather than smooth and round, which can create clogs, causing intense pain, organ … Continue reading Tackling sickle cell disease from within
CIRM awards $25 million for research and infrastructure programs
Stock image of a researcher The California Institute for Regenerative Medicine (CIRM) approved $25 million to fund multiple projects across discovery research, clinical research, and infrastructure programs. In particular, this funding supports 11 projects that will drive rigorous studies addressing key knowledge gaps in stem cell biology and regenerative medicine. Through this work, the program … Continue reading CIRM awards $25 million for research and infrastructure programs
State agency launches ‘Championing Change for Sickle Cell in California’ campaign
The California Institute for Regenerative Medicine (CIRM), established by the voters of California, is accelerating research and awareness of Sickle Cell Disease. The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, is proud to announce the launch of "Championing Change for Sickle Cell in California,” a pioneering … Continue reading State agency launches ‘Championing Change for Sickle Cell in California’ campaign
CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $56 million to fund various clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers. The awards will support seven projects—five clinical trials and two preclinical projects—in the Agency’s clinical program which provides funding for … Continue reading CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers